Form 4 Tracker
CYTOKINETICS INC
CYTK

92 insider filings · Latest: Oct 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 5, 2026Feb 6 1:17 AMAndrew CallosEVP, Chief Commercial Officer
Sale
15,000$61.93$929.0K50,440(D)

View →

Feb 2, 2026Feb 2 9:40 PMAndrew CallosEVP, Chief Commercial Officer
Sale
886$62.10$55.0K50,440(D)

View →

Jan 2, 2026Jan 2 9:34 PMANDREW CALLOS
Proposed Sale
59,570$63.54$3.8M—

View →

Dec 29, 2025Dec 29 9:27 PMANDREW CALLOS
Proposed Sale
1,809$63.11$114.2K—

View →

Dec 22, 2025Dec 22 9:26 PMWENDELL WIERENGA
Proposed Sale
20,000$62.72$1.3M—

View →

Dec 5, 2025Dec 5 9:26 PMANDREW CALLOS
Proposed Sale
53,528$66.54$3.6M—

View →

Dec 2, 2025Dec 2 9:25 PMJOHN T HENDERSON
Proposed Sale
8,750$66.05$577.9K—

View →

Dec 1, 2025Dec 1 9:21 PMEDWARD KAYE
Proposed Sale
28,064$68.13$1.9M—

View →

Nov 19, 2025Nov 19 9:20 PMB LYNNE PARSHALL
Proposed Sale
5,000$66.16$330.8K—

View →

Nov 11, 2025Nov 12 12:04 PMEDWARD KAYE
Proposed Sale
5,175$62.20$321.9K—

View →

Oct 27, 2025Oct 27 8:27 PMWENDELL WIERENGA
Proposed Sale
4,375$57.83$253.0K—

View →

Oct 21, 2025Oct 21 8:20 PMFADY MALIK
Proposed Sale
11,000$59.35$652.9K—

View →

Oct 6, 2025Oct 6 8:22 PMEDWARD KAYE
Proposed Sale
6,757$56.97$384.9K—

View →

Oct 1, 2025Oct 1 8:34 PMROBERT BLUM
Proposed Sale
15,000$54.96$824.4K—

View →

Sep 30, 2025Sep 30 8:29 PMEDWARD KAYE
Proposed Sale
6,695$53.89$360.8K—

View →

Sep 2, 2025Sep 2 8:36 PMROBERT HARRINGTON
Proposed Sale
4,300$35.33$151.9K—

View →

Sep 2, 2025Sep 2 8:28 PMEDWARD KAYE
Proposed Sale
6,756$35.33$238.7K—

View →

Jul 8, 2025Jul 8 8:22 PMFADY MALIK
Proposed Sale
14,000$33.36$467.0K—

View →

Jun 16, 2025Jun 16 8:21 PMROBERT BLUM
Proposed Sale
35,000$34.38$1.2M—

View →

Jun 5, 2025Jun 5 9:05 PMEDWARD KAYE
Proposed Sale
3,636$32.41$117.8K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 9, 2026Jun 9 9:40 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8044,386(D)

View →

Jun 1, 2026Jun 1 10:51 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,000$23.2639,000(D)

View →

May 27, 2026May 27 11:16 PMMuna BhanjiDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:14 PMJames M DalyDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:13 PMRobert Arthur HarringtonDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:12 PMJohn T HendersonDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:11 PMEdward M. Kaye MDDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:10 PMLynne B ParshallDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:09 PMRobert E LandryDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:08 PMWendell WierengaDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:07 PMNancy WysenskiDirector
Grant/Award
4,301$77.154,301(D)

View →

May 19, 2026May 20 8:00 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8047,886(D)

View →

May 5, 2026May 5 9:35 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8051,386(D)

View →

May 5, 2026May 5 8:20 PMWendell WierengaDirector
Option Exercise
4,032$12.400(D)

View →

May 5, 2026May 5 8:15 PMJohn T HendersonDirector
Option Exercise
20,000$7.610(D)

View →

May 5, 2026May 5 8:11 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
11,333$39.1313,070(D)

View →

May 1, 2026May 4 8:01 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,857$37.630(D)

View →

Apr 30, 2026Apr 30 8:22 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,000$23.2654,000(D)

View →

Apr 21, 2026Apr 21 8:22 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8054,886(D)

View →

Apr 7, 2026Apr 8 8:18 PMFady Ibraham MalikEVP Research & Development
Option Exercise
4,500$10.600(D)

View →